Astera Labs filings document a Nasdaq-listed semiconductor connectivity company serving rack-scale AI infrastructure. The company’s Form 8-K reports cover quarterly and annual operating results, product and demand commentary tied to PCIe 6, Scorpio smart fabric switches, signal conditioning and Smart Cable Modules, and material business updates.
ALAB regulatory disclosures also record its common stock listing on the Nasdaq Global Select Market, emerging growth company status, executive officer appointments and compensation arrangements, and material definitive agreements, including customer-linked warrant terms. Proxy materials describe annual meeting proposals, board elections, auditor ratification, executive compensation votes and stockholder voting mechanics.
Astera Labs, Inc. director and President/COO Gajendra Sanjay reported insider sales executed through estate-planning trusts. On May 7, 2026, trusts identified as "Trust 2" and "Trust 3" sold an aggregate of 49,361 shares of Common Stock in a series of open-market transactions under a pre-arranged Rule 10b5-1 trading plan adopted on December 2, 2025.
The reported weighted average sale prices span ranges disclosed in multiple footnotes, including transactions within bands such as $192.4400 to $193.4300 and up to higher ranges reflected in individual line items. Following these transactions, Sanjay continues to hold 1,531,301 shares directly, while the trusts still hold over 650,000 shares each. The filing states that the shares in Trust 2 and Trust 3 are owned directly by estate planning trusts, and Sanjay disclaims beneficial ownership except to the extent of any pecuniary interest.
Astera Labs, Inc. estate planning trusts reported sizeable planned share sales. On May 7, 2026, trusts associated with President and COO Gajendra Sanjay sold a total of 230,639 shares of Astera Labs common stock in a series of open-market transactions under a pre-arranged Rule 10b5-1 trading plan adopted on December 2, 2025. Individual blocks were sold at prices including $198.8237 and $213.49 per share. After these sales, one estate planning trust (Trust 1) reported holding 5,859,488 shares, while a second trust (Trust 2) reported holding 694,055 shares. The filing states that Sanjay disclaims beneficial ownership of these trust-held securities except to the extent of any pecuniary interest.
Astera Labs, Inc.’s CEO Mohan Jitendra reported multiple open-market sales of Common Stock on May 7, 2026, totaling 139,951 shares. The transactions were executed by a living trust associated with him under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025.
Sale prices ranged around $199–$206 per share, reported as weighted averages across several trades. After these sales, the living trust still held 3,989,757 shares of Astera Labs Common Stock, while Jitendra also held additional shares directly and through several estate planning trusts.
Astera Labs director Stefan A. Dyckerhoff reported open-market sales totaling 12,499 shares of Common Stock on May 7, 2026. The shares were sold at weighted-average prices of $201.102 and $199.00 per share under a Rule 10b5-1 trading plan adopted on December 1, 2025.
After these sales, Dyckerhoff holds 65,361 shares directly and additional indirect positions, including 332,160 shares held by a trust and 6,278 shares held by a limited partnership, where he disclaims beneficial ownership except for his pecuniary interest.
Morgan Stanley Smith Barney LLC submitted a Form 144 reporting an affiliate's proposed sale of 40,000 shares of Common Stock of ALAB. The filing lists an aggregate amount of $8,556,400.00 and reports 171,407,939 shares outstanding as of 05/07/2026. The shares were acquired on 11/21/2017 via a Private Acquisition from Issuer or an Affiliate.
Morgan Stanley Smith Barney LLC reported an intent to sell 40,000 shares of Common stock of ALAB via a Form 144. The filing shows an aggregate amount of $8,556,400.00 and lists 171,407,939 shares outstanding as of 05/07/2026. The shares were acquired 11/21/2017 in a Private Acquisition from Issuer or an Affiliate.
Morgan Stanley Smith Barney LLC filed a Form 144 notice reporting proposed sale of 200,000 common shares of ALAB. The securities were originally acquired 11/21/2017 in a private acquisition from the issuer or an affiliate. The filing shows a NASDAQ listing and a filing date of 05/07/2026.
ALAB notice of proposed sales of common stock under Rule 144 by affiliated holders, reporting recent dispositions and holdings.
The excerpt lists two reported sales by Stefan A. Dyckerhoff of 11,599 shares on 04/17/2026 and 13,399 shares on 04/20/2026, with dollar values shown. It also lists a pro-rata distribution to Sutter Hill Ventures A California LP of 8,333 shares (related dates shown).
Lynch Desmond reported acquisition or exercise transactions in this Form 4 filing.
Astera Labs, Inc. Chief Financial Officer Desmond Lynch reported two equity awards of common stock. On May 1, 2026, he received grants classified as awards of restricted stock units (RSUs) under the company’s 2024 Stock Option and Incentive Plan.
One award for 7,083 RSUs vests 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments thereafter, subject to his continuous service. A second award for 42,501 RSUs vests 100% on February 15, 2027, also contingent on ongoing service. Each RSU represents the right to receive one share of Astera Labs common stock, and the transactions were recorded at a grant price of $0.00 per share, reflecting compensation rather than open-market buying.
Lynch Desmond reported acquisition or exercise transactions in this Form 4 filing.
Astera Labs, Inc. Chief Financial Officer Desmond Lynch reported two equity awards of common stock. On May 1, 2026, he received grants classified as awards of restricted stock units (RSUs) under the company’s 2024 Stock Option and Incentive Plan.
One award for 7,083 RSUs vests 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments thereafter, subject to his continuous service. A second award for 42,501 RSUs vests 100% on February 15, 2027, also contingent on ongoing service. Each RSU represents the right to receive one share of Astera Labs common stock, and the transactions were recorded at a grant price of $0.00 per share, reflecting compensation rather than open-market buying.
Astera Labs delivered a very strong first quarter of 2026, combining rapid growth with high profitability. Revenue reached $308.4 million, up 93% from $159.4 million a year earlier, driven by higher demand and a richer mix of Scorpio, Aries, and Taurus products.
Gross margin improved to 76.3%, supported by favorable product mix. Operating income rose to $61.8 million, a 448% increase, and net income grew to $80.3 million, up 152% year over year. The company generated $74.6 million of operating cash flow and ended the quarter with $1.2 billion in cash, cash equivalents, and marketable securities, while total liabilities remained modest at $165.3 million.
Astera completed a $74.0 million acquisition of a data center acceleration business, adding technology and workforce and increasing goodwill to $87.7 million. Customer concentration remains high, with five customers each contributing at least 12% of revenue, primarily in Taiwan, Singapore, and China.
Astera Labs delivered a very strong first quarter of 2026, combining rapid growth with high profitability. Revenue reached $308.4 million, up 93% from $159.4 million a year earlier, driven by higher demand and a richer mix of Scorpio, Aries, and Taurus products.
Gross margin improved to 76.3%, supported by favorable product mix. Operating income rose to $61.8 million, a 448% increase, and net income grew to $80.3 million, up 152% year over year. The company generated $74.6 million of operating cash flow and ended the quarter with $1.2 billion in cash, cash equivalents, and marketable securities, while total liabilities remained modest at $165.3 million.
Astera completed a $74.0 million acquisition of a data center acceleration business, adding technology and workforce and increasing goodwill to $87.7 million. Customer concentration remains high, with five customers each contributing at least 12% of revenue, primarily in Taiwan, Singapore, and China.